Quince Therapeutics, Inc. - Common Stock, par value $0.0001 par value (QNCX)

Q: What does CUSIP 22053A107 represent in this 13F holders report?

CUSIP 22053A107 is the security identifier for QNCX - Quince Therapeutics, Inc. - Common Stock, par value $0.0001 par value used to aggregate holder disclosures.

Q: How many institutions held QNCX - Quince Therapeutics, Inc. - Common Stock, par value $0.0001 par value in Q4 2023?

41 institutional investors reported QNCX - Quince Therapeutics, Inc. - Common Stock, par value $0.0001 par value for Q4 2023. Use the holders table for investor-level position and value details.

CUSIP: 22053A107

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class: Equity / Common Stock, par value $0.0001 par value
Shares outstanding: 55,541,178
Total 13F shares: 7,451,323
Share change: -50,093
Total reported value: $7,825,763
Price per share: $1.05
Number of holders: 41
Value change: -$54,129
Number of buys: 10
Number of sells: 16

Quarterly Holders Quick Answers

What is CUSIP 22053A107?
CUSIP 22053A107 identifies QNCX - Quince Therapeutics, Inc. - Common Stock, par value $0.0001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Institutional Holders of Quince Therapeutics, Inc. - Common Stock, par value $0.0001 par value (QNCX) as of Q4 2023

As of 31 Dec 2023, Quince Therapeutics, Inc. - Common Stock, par value $0.0001 par value (QNCX) was held by 41 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,451,323 shares. The largest 10 holders included TANG CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, EPIQ Capital Group, LLC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, Alphabet Inc., BANK OF AMERICA CORP /DE/, BRIDGEWAY CAPITAL MANAGEMENT, LLC, and JANE STREET GROUP, LLC. This page lists 41 institutional shareholders reporting positions in this security for the Q4 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.